BNTX logo

BioNTech SE (BNTX) Accounts payable

annual accounts payable:

$444.01M+$52.70M(+13.47%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BNTX annual accounts payable is $444.01 million, with the most recent change of +$52.70 million (+13.47%) on December 31, 2024.
  • During the last 3 years, BNTX annual accounts payable has risen by +$262.86 million (+145.10%).
  • BNTX annual accounts payable is now at all-time high.

Performance

BNTX Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXbalance sheet metrics

quarterly accounts payable:

$480.34M+$36.33M(+8.18%)
March 1, 2025

Summary

  • As of today (May 29, 2025), BNTX quarterly accounts payable is $480.34 million, with the most recent change of +$36.33 million (+8.18%) on March 1, 2025.
  • Over the past year, BNTX quarterly accounts payable has increased by +$157.66 million (+48.86%).
  • BNTX quarterly accounts payable is now -49.16% below its all-time high of $944.88 million, reached on June 30, 2024.

Performance

BNTX quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

BNTX Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.5%+48.9%
3 y3 years+145.1%+247.9%
5 y5 years+1833.8%+2142.9%

BNTX Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+145.1%-49.2%+1373.2%
5 y5-yearat high+1833.8%-49.2%+2142.9%
alltimeall timeat high+6654.7%-49.2%+2402.6%

BNTX Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$480.34M(+8.2%)
Dec 2024
$444.01M(+13.5%)
$444.01M(-47.9%)
Sep 2024
-
$851.75M(-9.9%)
Jun 2024
-
$944.88M(+192.8%)
Mar 2024
-
$322.67M(-17.5%)
Dec 2023
$391.31M(+78.8%)
$391.31M(+66.0%)
Sep 2023
-
$235.73M(-5.1%)
Jun 2023
-
$248.43M(+662.0%)
Mar 2023
-
$32.60M(-85.1%)
Dec 2022
$218.88M(+20.8%)
$218.88M(-24.9%)
Sep 2022
-
$291.43M(-4.2%)
Jun 2022
-
$304.08M(+120.2%)
Mar 2022
-
$138.06M(-23.8%)
DateAnnualQuarterly
Dec 2021
$181.16M(+44.0%)
$181.16M(-39.7%)
Sep 2021
-
$300.30M(-3.9%)
Jun 2021
-
$312.62M(+151.1%)
Mar 2021
-
$124.50M(-1.1%)
Dec 2020
$125.82M(+448.0%)
$125.82M(+155.7%)
Sep 2020
-
$49.21M(+22.6%)
Jun 2020
-
$40.14M(+87.4%)
Mar 2020
-
$21.42M(-6.7%)
Dec 2019
$22.96M(-51.9%)
$22.96M(-3.8%)
Sep 2019
-
$23.87M(+24.3%)
Jun 2019
-
$19.19M(-59.8%)
Dec 2018
$47.72M(-24.3%)
$47.72M
Dec 2017
$63.03M(+858.9%)
-
Dec 2016
$6.57M
-

FAQ

  • What is BioNTech SE annual accounts payable?
  • What is the all time high annual accounts payable for BioNTech SE?
  • What is BioNTech SE annual accounts payable year-on-year change?
  • What is BioNTech SE quarterly accounts payable?
  • What is the all time high quarterly accounts payable for BioNTech SE?
  • What is BioNTech SE quarterly accounts payable year-on-year change?

What is BioNTech SE annual accounts payable?

The current annual accounts payable of BNTX is $444.01M

What is the all time high annual accounts payable for BioNTech SE?

BioNTech SE all-time high annual accounts payable is $444.01M

What is BioNTech SE annual accounts payable year-on-year change?

Over the past year, BNTX annual accounts payable has changed by +$52.70M (+13.47%)

What is BioNTech SE quarterly accounts payable?

The current quarterly accounts payable of BNTX is $480.34M

What is the all time high quarterly accounts payable for BioNTech SE?

BioNTech SE all-time high quarterly accounts payable is $944.88M

What is BioNTech SE quarterly accounts payable year-on-year change?

Over the past year, BNTX quarterly accounts payable has changed by +$157.66M (+48.86%)
On this page